Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Imagem de Miniatura
Arquivos
art_BIKBOV_Global_regional_and_national_burden_of_chronic_kidney_2020.PDF.pdf (944.6 KB)
Citações na Scopus
2940
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
BIKBOV, Boris
PURCELL, Carrie
LEVEY, Andrew S.
SMITH, Mari
ABDOLI, Amir
ABEBE, Molla
ADEBAYO, Oladimeji M.
AFARIDEH, Mohsen
AGARWAL, Sanjay Kumar
AGUDELO-BOTERO, Marcela
Citação
LANCET, v.395, n.10225, p.709-733, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. Methods The main data sources we used were published literature, vital registration systems, end-stage kidney disease registries, and household surveys. Estimates of CKD burden were produced using a Cause of Death Ensemble model and a Bayesian meta-regression analytical tool, and induded incidence, prevalence, years lived with disability, mortality, years of life lost, and disability-adjusted life-years (DALYs). A comparative risk assessment approach was used to estimate the proportion of cardiovascular diseases and gout burden attributable to impaired kidney function. Findings Globally, in 2017,1.2 million (95% uncertainty interval [UI] 1.2 to 1.3) people died from CKD. The global all-age mortality rate from CKD increased 41.5% (95% UI 35.2 to 46.5) between 1990 and 2017, although there was no significant change in the age-standardised mortality rate (2.8%, -1.5 to 6.3). In 2017,697.5 million (95% UI 649.2 to 752.0) cases of all-stage CKD were recorded, for a global prevalence of 9.1% (8.5 to 9.8). The global all-age prevalence of CKD increased 29.3% (95% UI 26.4 to 32.6) since 1990, whereas the age-standardised prevalence remained stable (1.2%, -1.1 to 3.5). CKD resulted in 35.8 million (95% UI 33.7 to 38.0) DALYs in 2017, with diabetic nephropathy accounting for almost a third of DALYs. Most of the burden of CKD was concentrated in the three lowest quintiles of Socio-demographic Index (SDI). In several regions, particularly Oceania, sub-Saharan Africa, and Latin America, the burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected. 1.4 million (95% UI 1.2 to 1.6) cardiovascular disease-related deaths and 25.3 million (22.2 to 28.9) cardiovascular disease DALYs were attributable to impaired kidney function. Interpretation Kidney disease has a major effect on global health, both as a direct cause of global morbidity and mortality and as an important risk factor for cardiovascular disease. CKD is largely preventable and treatable and deserves greater attention in global health policy decision making, particularly in locations with low and middle SDI.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/37663
Referências
  1. [Anonymous], 2013, KIDNEY INT S, V3, P1, DOI 10.1038/kisup.2012.73
  2. [Anonymous], 2017, TRACK UN HLTH COV 20
  3. Ashuntantang G, 2017, LANCET GLOB HEALTH, V5, pE408, DOI [10.1016/s2214-109x(17)30057-8, 10.1016/S2214-109X(17)30057-8]
  4. Barreto SM, 2016, J EPIDEMIOL COMMUN H, V70, P380, DOI 10.1136/jech-2015-205834
  5. Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046
  6. Bikbov B, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0569-8
  7. Bikbov B, 2018, NEPHRON, V139, P313, DOI 10.1159/000489897
  8. Bottomley MJ, 2011, NEPHRON CLIN PRACT, V117, pC348, DOI 10.1159/000321515
  9. Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542
  10. Bui AL, 2009, AM J KIDNEY DIS, V53, P389, DOI 10.1053/j.ajkd.2008.06.025
  11. Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181
  12. Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077
  13. Soriano LC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3272
  14. Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A
  15. Chang AR, 2019, PENNSYLVANIA GEISING
  16. Chronic Kidney Disease Prognosis Consortium (CKD-PC), 2019, CHRON KIDN DIS PROGN
  17. Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617
  18. Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
  19. Correa-Rotter R, 2014, AM J KIDNEY DIS, V63, P506, DOI 10.1053/j.ajkd.2013.10.062
  20. Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368
  21. Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610
  22. De Graauw J, 2011, NEPHROL DIAL TRANSPL, V26, P927, DOI 10.1093/ndt/gfq455
  23. Delanaye P, 2017, CLIN KIDNEY J, V10, P370, DOI 10.1093/ckj/sfw154
  24. Ekrikpo UE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195443
  25. Ene-Iordache B, 2016, LANCET GLOB HEALTH, V4, pE307, DOI 10.1016/S2214-109X(16)00071-1
  26. Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]
  27. Garcia-Garcia G, 2007, J AM SOC NEPHROL, V18, P1922, DOI 10.1681/ASN.2006121388
  28. Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
  29. Gifford FJ, 2011, QJM-INT J MED, V104, P1045, DOI 10.1093/qjmed/hcr122
  30. Glassock RJ, 2017, NAT REV NEPHROL, V13, P104, DOI [10.1038/nmeph.2016.163, 10.1038/nrneph.2016.163]
  31. Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
  32. Go DS, 2019, NEPHROLOGY, V24, P56, DOI 10.1111/nep.13203
  33. Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273
  34. Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81
  35. Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710
  36. Hirst JA, 2018, BRIT J GEN PRACT, V68, pE524, DOI 10.3399/bjgp18X697937
  37. Howard K, 2010, VALUE HEALTH, V13, P196, DOI 10.1111/j.1524-4733.2009.00668.x
  38. Ichiho Henry M, 2013, Hawaii J Med Public Health, V72, P10
  39. Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x
  40. Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130
  41. James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7
  42. Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426
  43. Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
  44. Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002
  45. Komenda P, 2014, AM J KIDNEY DIS, V63, P789, DOI 10.1053/j.ajkd.2013.12.012
  46. Kondo M, 2012, CLIN EXP NEPHROL, V16, P279, DOI 10.1007/s10157-011-0567-1
  47. Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171
  48. Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]
  49. Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
  50. Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
  51. Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9
  52. Maione A, 2011, NEPHROL DIAL TRANSPL, V26, P2827, DOI 10.1093/ndt/gfq792
  53. Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x
  54. Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3
  55. Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007
  56. Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6
  57. Matsushita K, 2012, AM J KIDNEY DIS, V60, P241, DOI 10.1053/j.ajkd.2012.03.016
  58. Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954
  59. Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5
  60. Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016
  61. McAdams-DeMarco MA, 2012, J CLIN HYPERTENS, V14, P675, DOI 10.1111/j.1751-7176.2012.00674.x
  62. Mercado-Martinez FJ, 2017, NURS INQ, V24, DOI 10.1111/nin.12163
  63. Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909
  64. Murray CJL, 2018, LANCET, V392, P1995, DOI 10.1016/s0140-6736(18)32278-5
  65. Navaneethan SD, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-3
  66. Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x
  67. O'Hare AM, 2004, J AM SOC NEPHROL, V15, P1046, DOI 10.1097/01.ASN.0000119574.27772.FD
  68. Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095
  69. Rajapurkar MM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-10
  70. Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7
  71. Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1917, DOI 10.1681/ASN.2012040390
  72. Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
  73. Shara NM, 2012, AM J KIDNEY DIS, V60, P795, DOI 10.1053/j.ajkd.2012.06.015
  74. Smart NA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007333.pub2
  75. Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]
  76. Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6
  77. Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
  78. Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026
  79. Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562
  80. Trifio G, 2013, ANN RHEUM DIS, V72, P694, DOI 10.1136/annrheumdis-2011-201254
  81. Trivedi HS, 2002, AM J KIDNEY DIS, V39, P721, DOI 10.1053/ajkd.2002.31990
  82. Tuot DS, 2016, CLIN J AM SOC NEPHRO, V11, P1566, DOI 10.2215/CJN.00490116
  83. United States Renal Data System, 2016, USRDS ANN DAT REP EP
  84. Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204
  85. Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6
  86. Weil E Jennifer, 2006, Ethn Dis, V16, pS2
  87. Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6
  88. Whaley-Connell A, 2012, AM J MED, V125, P661, DOI 10.1016/j.amjmed.2011.11.026
  89. White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011
  90. Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]
  91. Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03